Biote Stock (NASDAQ: BTMD) stock price, news, charts, stock research, profile.
Open | $7.48 |
Close | $7.47 |
Volume / Avg. | 2.06M / 163.88K |
Day Range | 7.32 - 7.55 |
52 Wk Range | 3.65 - 8.22 |
Market Cap | $226.49M |
P/E Ratio | 16.07 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 68 |
Short Interest | 5.4% |
Days to Cover | 7.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biote (NASDAQ:BTMD) through any online brokerage.
Other companies in Biote’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), Xeris Biopharma Holdings (NASDAQ:XERS) and Aquestive Therapeutics (NASDAQ:AQST).
There is no analysis for Biote.
Biote has a consensus price target of $8.65.
The stock price for Biote (NASDAQ: BTMD) is $7.47 last updated June 28, 2024 at 4:19 PM EDT.
There are no upcoming dividends for Biote.
Biote’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Biote.
Biote is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.